Abstract:Development of stability-indicating method by liquid chromatography are always a challenge for analytical researchers. A traditional way is by varying one chromatographic parameter at a time assessing the responses from each test. Recent international guidelines encourage the implementation of systematic approaches in analytical development, such as Analytical Quality by Design (AQbD). The aim of this paper was to develop, using the AQbD approach, an efficient and selective stability-indicating method by high performance liquid chromatography for nevirapine and its related substances. The Analytical Target Profile (ATP) and the Critical Method Attributes (CMA) were determined. Through the risk assessment studies, the high-risk analytical conditions were considered as Critical Method Parameters (CMP) and they were screened and optimized by Design of Experiment (DoE). The Method Operable Design Region (MODR) was defined using Monte Carlo Simulation. A control strategy was established by the definition of the system suitability of the analytical procedure. Optimal chromatographic conditions were achieved using an isocratic elution consisting of a mixture of 5 mM ammonium formate buffer pH 5.4/acetonitrile/methanol (60:20:20), with a flow rate of 1.0 mL/min, oven temperature of 30 °C, injection volume of 5 μL and an ACE C18 250 mm x 4,6 mm x 5 μm chromatographic column. Finally, analytical validation and forced degradation studies confirmed the performance of the analytical method. From the estimation of measurement uncertainty, strategies were outlined so that the method is fit for purpose throughout its life cycle. Additionally, guard bands were defined, changing the specification for nevirapine quantification from 90 % to 100 % to the acceptance zone of 92.1–107.9 %. The AQbD method development provided strong justifications for the selection of important parameters for nevirapine method during regulatory filling. Furthermore, with the pass/fail decision rule using guard band, restricted acceptance zones were defined, reducing the risk to the consumer of taking a drug product whose batch was inadequately approved.

Quantum chemical and experimental study of closed-loop reactant of nevirapine

Improved Synthesis of 2‐Chloro‐3‐amino‐4‐methylpyridine

Quantitative Structure_Activity Relationship Studies of Nevirapine Derivatives Anti-HIV Drug using New Three-dimensional Structure Descriptors

Exploring Co-Amorphous Formulations Of Nevirapine: Insights From Computational, Thermal, And Solubility Analyses

Application of thioglycolic acid capped nano-ZnS as a fluorescence probe for the determination of nevirapine

Study on the interaction between HIV reverse transcriptase and its non-nucleoside inhibitor nevirapine by capillary electrophoresis.

Nevirapine Pharmaceutical Cocrystal: Design, Development and Formulation

Insight into the structural requirements of narlaprevir-type inhibitors of NS3/NS4A protease based on HQSAR and molecular field analyses.

Investigation of Nirmatrelvir Epimerization Occurred in Analytical Sample Solution by Using High Resolution LC-MSn, NMR, and Hydrogen/deuterium Exchange Study.

Disubstituted pyrimidine-5-carboxamide derivatives as novel HIV-1 NNRTIs: Crystallographic overlay-based molecular design, synthesis, and biological evaluation

Synthesis and anti-HCV activity of β-d-2'-deoxy-2'-α-chloro-2'-β-fluoro and β-d-2'-deoxy-2'-α-bromo-2'-β-fluoro nucleosides and their phosphoramidate prodrugs

Design, Synthesis, and Biological Evaluation of 1-[(2-benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils As Potent Hiv-1 Non-Nucleoside Reverse Transcriptase Inhibitors with an Improved Drug Resistance Profile

The Design And Synthesis Of 9-Phenylcyclohepta[D]Pyrimidine-2,4-Dione Derivatives As Potent Non-Nucleoside Inhibitors Of Hiv Reverse Transcriptase

Synergy of Small Antiviral Molecules on a Black-Phosphorus Nanocarrier: Machine Learning and Quantum Chemical Simulation Insights

Design of novel broad-spectrum antiviral nucleoside analogues using natural bases ring-opening strategy

Physicochemical characterization of the various solid forms of carbovir, an antiviral nucleoside

Computational investigation of novel synthetic analogs of C-1'β substituted remdesivir against RNA-dependent RNA-polymerase of SARS-CoV-2

Structural flexibility of favipiravir and its structural analogues in solutions: experimental and computational insight

Application of analytical quality by design (AQbD) for stability-indicating method development for quantification of nevirapine and its degradation products

Design of Biphenyl-Substituted Diarylpyrimidines with a Cyanomethyl Linker as HIV-1 NNRTIs via a Molecular Hybridization Strategy.

Solvent effects on spectroscopic, electronic, and topological analyses, Hirshfeld surface, ADME, and molecular docking studies on antiviral pyridine carboxamide derivatives